Literature DB >> 35298903

Protein tyrosine phosphatase receptor δ serves as the orexigenic asprosin receptor.

Ila Mishra1, Wei Rose Xie1, Juan C Bournat2, Yang He3, Chunmei Wang3, Elizabeth Sabath Silva1, Hailan Liu3, Zhiqiang Ku4, Yinghua Chen5, Bernadette O Erokwu6, Peilin Jia7, Zhongming Zhao7, Zhiqiang An4, Chris A Flask6, Yanlin He8, Yong Xu3, Atul R Chopra9.   

Abstract

Asprosin is a fasting-induced glucogenic and centrally acting orexigenic hormone. The olfactory receptor Olfr734 is known to be the hepatic receptor for asprosin that mediates its effects on glucose production, but the receptor for asprosin's orexigenic function has been unclear. Here, we have identified protein tyrosine phosphatase receptor δ (Ptprd) as the orexigenic receptor for asprosin. Asprosin functions as a high-affinity Ptprd ligand in hypothalamic AgRP neurons, regulating the activity of this circuit in a cell-autonomous manner. Genetic ablation of Ptprd results in a strong loss of appetite, leanness, and an inability to respond to the orexigenic effects of asprosin. Ablation of Ptprd specifically in AgRP neurons causes resistance to diet-induced obesity. Introduction of the soluble Ptprd ligand-binding domain in the circulation of mice suppresses appetite and blood glucose levels by sequestering plasma asprosin. Identification of Ptprd as the orexigenic asprosin receptor creates a new avenue for the development of anti-obesity therapeutics.
Copyright © 2022 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AgRP; Ptprd; appetite; asprosin; hypothalamus; metabolism; obesity; receptor

Mesh:

Substances:

Year:  2022        PMID: 35298903      PMCID: PMC8986618          DOI: 10.1016/j.cmet.2022.02.012

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   31.373


  53 in total

1.  An Anatomically Resolved Mouse Brain Proteome Reveals Parkinson Disease-relevant Pathways.

Authors:  Sung Yun Jung; Jong Min Choi; Maxime W C Rousseaux; Anna Malovannaya; Jean J Kim; Joachim Kutzera; Yi Wang; Yin Huang; Weimin Zhu; Suman Maity; Huda Yahya Zoghbi; Jun Qin
Journal:  Mol Cell Proteomics       Date:  2017-02-02       Impact factor: 5.911

2.  Loss of the tyrosine phosphatase PTPRD leads to aberrant STAT3 activation and promotes gliomagenesis.

Authors:  Berenice Ortiz; Armida W M Fabius; Wei H Wu; Alicia Pedraza; Cameron W Brennan; Nikolaus Schultz; Kenneth L Pitter; Jacqueline F Bromberg; Jason T Huse; Eric C Holland; Timothy A Chan
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-19       Impact factor: 11.205

Review 3.  Gender-related issues in the pharmacology of new anti-obesity drugs.

Authors:  Mauro Cataldi; Giovanna Muscogiuri; Silvia Savastano; Luigi Barrea; Bruna Guida; Maurizio Taglialatela; Annamaria Colao
Journal:  Obes Rev       Date:  2018-12-27       Impact factor: 9.213

4.  Leptin Signaling in AgRP Neurons Modulates Puberty Onset and Adult Fertility in Mice.

Authors:  Olivia K Egan; Megan A Inglis; Greg M Anderson
Journal:  J Neurosci       Date:  2017-03-08       Impact factor: 6.167

5.  Inactivation of signal transducer and activator of transcription 3 in proopiomelanocortin (Pomc) neurons causes decreased pomc expression, mild obesity, and defects in compensatory refeeding.

Authors:  Allison W Xu; Linda Ste-Marie; Christopher B Kaelin; Gregory S Barsh
Journal:  Endocrinology       Date:  2006-10-05       Impact factor: 4.736

6.  Saliva and Blood Asprosin Hormone Concentration Associated with Obesity.

Authors:  Kader Ugur; Suleyman Aydin
Journal:  Int J Endocrinol       Date:  2019-03-27       Impact factor: 3.257

7.  Leptin targets in the mouse brain.

Authors:  Michael M Scott; Jennifer L Lachey; Scott M Sternson; Charlotte E Lee; Carol F Elias; Jeffrey M Friedman; Joel K Elmquist
Journal:  J Comp Neurol       Date:  2009-06-10       Impact factor: 3.215

8.  Sensitive asprosin detection in clinical samples reveals serum/saliva correlation and indicates cartilage as source for serum asprosin.

Authors:  Yousef A T Morcos; Steffen Lütke; Antje Tenbieg; Franz-Georg Hanisch; Galyna Pryymachuk; Nadin Piekarek; Thorben Hoffmann; Titus Keller; Ruth Janoschek; Anja Niehoff; Frank Zaucke; Jörg Dötsch; Eva Hucklenbruch-Rother; Gerhard Sengle
Journal:  Sci Rep       Date:  2022-01-25       Impact factor: 4.379

9.  Loss-of-Function PTPRD Mutations Lead to Increased STAT3 Activation and Sensitivity to STAT3 Inhibition in Head and Neck Cancer.

Authors:  Noah D Peyser; Yu Du; Hua Li; Vivian Lui; Xiao Xiao; Timothy A Chan; Jennifer R Grandis
Journal:  PLoS One       Date:  2015-08-12       Impact factor: 3.240

10.  The Asprosin-OLFR734 module regulates appetitive behaviors.

Authors:  Yang Liu; Aijun Long; Liqun Chen; Liangjie Jia; Yiguo Wang
Journal:  Cell Discov       Date:  2020-04-14       Impact factor: 10.849

View more
  5 in total

1.  Increased plasma asprosin levels are associated with overeating and loss of control in drug-free bulimia nervosa.

Authors:  Yanran Hu; Qing Kang; Chen Chen; Lei Guo; Jue Chen
Journal:  Eat Weight Disord       Date:  2022-06-29       Impact factor: 3.008

2.  Overexpression and ELISA-based detection of asprosin in cultured cells and mice.

Authors:  Ila Mishra; Atul R Chopra
Journal:  STAR Protoc       Date:  2022-10-12

Review 3.  The Effects of Asprosin on Exercise-Intervention in Metabolic Diseases.

Authors:  Lifei Liu; Yuhao Liu; Mei Huang; Miao Zhang; Chenyu Zhu; Xi Chen; Samuel Bennett; Jiake Xu; Jun Zou
Journal:  Front Physiol       Date:  2022-07-11       Impact factor: 4.755

Review 4.  Dietary regulation in health and disease.

Authors:  Qi Wu; Zhi-Jie Gao; Xin Yu; Ping Wang
Journal:  Signal Transduct Target Ther       Date:  2022-07-23

5.  Differential Regulation of Genes by the Glucogenic Hormone Asprosin in Ovarian Cancer.

Authors:  Rachel Kerslake; Cristina Sisu; Suzana Panfilov; Marcia Hall; Nabeel Khan; Jeyarooban Jeyaneethi; Harpal Randeva; Ioannis Kyrou; Emmanouil Karteris
Journal:  J Clin Med       Date:  2022-10-08       Impact factor: 4.964

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.